Trial Profile
Multicenter study of the efficacy of tolvaptan for patients with refractory ascites.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Therapeutic Use
- 12 Aug 2020 Status changed from active, no longer recruiting to completed.
- 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Mar 2014 New trial record